Imatinib treatments have long-term impact on placentation and embryo survival
Author:
Funder
Goldhirsh-Yellin Foundation Fellowship
American Cancer Society
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Link
http://www.nature.com/articles/s41598-019-39134-0.pdf
Reference48 articles.
1. Beinortas, T. et al. Chronic myeloid leukemia incidence, survival and accessibility of tyrosine kinase inhibitors: a report from population-based Lithuanian haematological disease registry 2000–2013. BMC Cancer 16, 198, https://doi.org/10.1186/s12885-016-2238-9 (2016).
2. Hoglund, M. et al. Tyrosine kinase inhibitor usage, treatment outcome, and prognostic scores in CML: report from the population-based Swedish CML registry. Blood 122, 1284–1292, https://doi.org/10.1182/blood-2013-04-495598 (2013).
3. Hoglund, M., Sandin, F. & Simonsson, B. Epidemiology of chronic myeloid leukaemia: an update. Annals of hematology 94(Suppl 2), S241–247, https://doi.org/10.1007/s00277-015-2314-2 (2015).
4. Kantarjian, H. et al. Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia. The New England journal of medicine 346, 645–652, https://doi.org/10.1056/NEJMoa011573 (2002).
5. Demetri, G. D. et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. The New England journal of medicine 347, 472–480, https://doi.org/10.1056/NEJMoa020461 (2002).
Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Chronic Myeloid Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology;Journal of the National Comprehensive Cancer Network;2024-02
2. Drug repurposing for cancer;Progress in Molecular Biology and Translational Science;2024
3. Fertility and pregnancy in chronic myeloid leukemia: real-world experience from an Indian tertiary care institution;Annals of Hematology;2023-06-15
4. Diagnosis, Treatment, and Prognosis of Patients with Primary Familial Gastrointestinal Stromal Tumor: A Case Report and Literature Review;The Oncologist;2023-06-13
5. Berberine hydrochloride alleviates imatinib mesylate – induced cardiotoxicity through the inhibition of Nrf2-dependent ferroptosis;Food & Function;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3